Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for IDP-122 topical lotion in moderate-to-severe plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial assessing safety and efficacy of IDP-118 lotion for plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) [Phase 4]
Phase 4 clinical trial update for a Danish population-based assessment addressing psoriasis and psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Granulocytapheresis in Psoriasis [NA]
A clinical trial update indicates termination for granulocytapheresis in psoriasis, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis [Phase 1, Phase 2]
A clinical trial update on ESR-114 topical treatment for psoriatic plaque, completed phases 1 and 2 assessing safety, pharmacokinetics, and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris [Phase 1]
Phase 1 clinical trial update for ixekizumab in Chinese participants with psoriasis vulgaris has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial comparing methotrexate to secukinumab safety in psoriasis patients with metabolic syndrome; status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis [Phase 1]
Phase 1 trial evaluating safety, tolerability, and efficacy of topical PF-06763809 in mild to moderate chronic plaque psoriasis; completed w…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis [NA]
Clinical trial update on excimer laser phototherapy for psoriasis; study is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for guselkumab (CNTO 1959) in moderate to severe plaque psoriasis; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. [Phase 2]
Phase 2 randomized trial evaluating a dipeptidyl peptidase-4 inhibitor in patients with psoriasis and type 2 diabetes; results posted after …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Taltz in Combination With Enstilar for Psoriasis [Phase 4]
Phase 4 trial update investigating Taltz in combination with Enstilar for psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Duobrii in Combination With Biologics [Phase 4]
Phase 4 clinical trial update evaluating Duobrii in combination with biologics for psoriasis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis [Phase 2]
Phase 2 open-label pilot study assessing CC1004 in severe plaque psoriasis, focusing on pharmacodynamics, pharmacokinetics, safety, and prel…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis [Phase 2]
Phase 2 double-blind, randomized, placebo-controlled trial of CC-10004 in moderate-to-severe plaque psoriasis completed.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis [Phase 2]
Phase 2 trial evaluating two doses of apremilast (CC-10004) in Japanese patients with moderate-to-severe plaque-type psoriasis; study comple…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Observational post-marketing study assessing AbbVie's Humira effectiveness in psoriasis completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients [Phase 2]
Phase 2 trial update showing initial dosing of BI 655130 in patients with palmoplantar pustulosis (a form of psoriasis); results have been p…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Using an Internet Study to Improve Adherence for Psoriasis Patients [EARLY_Phase 1]
Phase 1 trial exploring an internet-based approach to improve adherence in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of MC2-01 Cream for psoriasis has completed, with results posted in October 2019…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis [Phase 1, Phase 2]
Clinical trial update for BMS-986251 (oral) in healthy participants and patients with psoriasis and rheumatoid arthritis; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath [Phase 2]
Phase 2 clinical trial update involving Indigo Naturalis and Chinese medicine medicated bath for psoriasis.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
A completed clinical trial evaluating the safety and effectiveness of etanercept for pediatric psoriasis with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial comparing guselkumab to secukinumab for moderate to severe plaque psoriasis has completed with results posted.